HHLR ADVISORS, LTD. - Q4 2019 holdings

$8.03 Billion is the total value of HHLR ADVISORS, LTD.'s 54 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 100.0% .

 Value Shares↓ Weighting
NTGN ExitNEON THERAPEUTICS INC$0-60,000
-100.0%
-0.00%
GSAHWS ExitGS ACQUISITION HLDGS CORP*w exp 06/12/202$0-333,333
-100.0%
-0.01%
CNST ExitCONSTELLATION PHARMCETICLS I$0-246,883
-100.0%
-0.02%
WUBA Exit58 COM INCspon adr rep a$0-57,964
-100.0%
-0.04%
NOAH ExitNOAH HLDGS LTDspon ads cl a$0-481,220
-100.0%
-0.19%
MRNA ExitMODERNA INC$0-978,434
-100.0%
-0.21%
MELI ExitMERCADOLIBRE INC$0-32,600
-100.0%
-0.25%
HTHT ExitHUAZHU GROUP LTDsponsored ads$0-611,490
-100.0%
-0.28%
NIO ExitNIO INCspon ads$0-13,368,900
-100.0%
-0.29%
SQ ExitSQUARE INCcl a$0-428,675
-100.0%
-0.36%
AAPL ExitAPPLE INC$0-127,759
-100.0%
-0.39%
TSLA ExitTESLA INC$0-171,400
-100.0%
-0.57%
MOMO ExitMOMO INCadr$0-1,385,000
-100.0%
-0.59%
CVET ExitCOVETRUS INC$0-3,958,198
-100.0%
-0.65%
AMZN ExitAMAZON COM INC$0-48,456
-100.0%
-1.16%
FB ExitFACEBOOK INCcl a$0-1,280,763
-100.0%
-3.14%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings